Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 4
1986 1
1987 3
1988 6
1989 20
1990 14
1991 27
1992 26
1993 44
1994 53
1995 51
1996 43
1997 49
1998 50
1999 58
2000 55
2001 58
2002 66
2003 59
2004 68
2005 76
2006 74
2007 72
2008 68
2009 81
2010 74
2011 62
2012 46
2013 67
2014 59
2015 52
2016 38
2017 27
2018 34
2019 37
2020 54
2021 58
2022 49
2023 32
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,666 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.
Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I. Chollet F, et al. Lancet Neurol. 2011 Feb;10(2):123-30. doi: 10.1016/S1474-4422(10)70314-8. Epub 2011 Jan 7. Lancet Neurol. 2011. PMID: 21216670 Clinical Trial.
We therefore aimed to investigate whether fluoxetine would enhance motor recovery if given soon after an ischaemic stroke to patients who have motor deficits. ...This trial is registered with ClinicalTrials.gov, number NCT00657163. FINDINGS: 118 patients were randomly assi …
We therefore aimed to investigate whether fluoxetine would enhance motor recovery if given soon after an ischaemic stroke to patients …
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. March J, et al. JAMA. 2004 Aug 18;292(7):807-20. doi: 10.1001/jama.292.7.807. JAMA. 2004. PMID: 15315995 Clinical Trial.
Placebo and fluoxetine alone were administered double-blind; CBT alone and CBT with fluoxetine were administered unblinded. ...Compared with fluoxetine alone (P =.02) and CBT alone (P =.01), treatment of fluoxetine with CBT was superior. ...
Placebo and fluoxetine alone were administered double-blind; CBT alone and CBT with fluoxetine were administered unblinded. .. …
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M. Davey CG, et al. Lancet Psychiatry. 2019 Sep;6(9):735-744. doi: 10.1016/S2215-0366(19)30215-9. Epub 2019 Jul 29. Lancet Psychiatry. 2019. PMID: 31371212 Clinical Trial.
Patients were randomly assigned (1:1) to receive CBT for 12 weeks, plus either fluoxetine or placebo. Participants began on one 20 mg capsule of fluoxetine or one placebo pill per day. ...FINDINGS: 153 participants (mean age 19.6 years [SD 2.7]) were enrolled from F …
Patients were randomly assigned (1:1) to receive CBT for 12 weeks, plus either fluoxetine or placebo. Participants began on one 20 mg …
Comparison of fluoxetine with other selective serotonin reuptake inhibitors in the treatment of premature ejaculation: A systematic review and meta-analysis.
Liu Q, Gao H, Huang Y, Wang M, Jiang H, Dai Y, Zhang X. Liu Q, et al. Andrologia. 2022 Sep;54(8):e14500. doi: 10.1111/and.14500. Epub 2022 Jun 27. Andrologia. 2022. PMID: 35760074 Review.
Our meta-analysis includes a total of ten trials to investigate into the differences in treatment efficacy and safety between fluoxetine and other medicines. The findings revealed that fluoxetine was more effective than placebo in treating PE, whereas sertraline and …
Our meta-analysis includes a total of ten trials to investigate into the differences in treatment efficacy and safety between fluoxetine
Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents - systematic review and meta-analysis.
Kryst J, Majcher-Maślanka I, Chocyk A. Kryst J, et al. Pharmacol Rep. 2022 Oct;74(5):920-946. doi: 10.1007/s43440-022-00420-w. Epub 2022 Sep 24. Pharmacol Rep. 2022. PMID: 36151445 Free PMC article. Review.
No significant effects of chronic adolescent fluoxetine on depression-like behavior were reported in naive animals, while in stress-exposed rodents chronic adolescent fluoxetine significantly decreased immobility time in the forced swim test compared to vehicle. ... …
No significant effects of chronic adolescent fluoxetine on depression-like behavior were reported in naive animals, while in stress-e …
The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials.
Wu J, Qin G. Wu J, et al. Int J Clin Pharm. 2023 Aug;45(4):839-846. doi: 10.1007/s11096-023-01573-1. Epub 2023 Apr 20. Int J Clin Pharm. 2023. PMID: 37081168 Review.
BACKGROUND: Fluoxetine is one of the selective serotonin reuptake inhibitors that can improve motor and function recovery after a stroke. ...There were no significant differences between the groups regarding gastrointestinal adverse reactions (P > 0.05), drowsiness (P & …
BACKGROUND: Fluoxetine is one of the selective serotonin reuptake inhibitors that can improve motor and function recovery after a str …
Fluoxetine for stroke recovery: Meta-analysis of randomized controlled trials.
Mead GE, Legg L, Tilney R, Hsieh CF, Wu S, Lundström E, Rudberg AS, Kutlubaev M, Dennis MS, Soleimani B, Barugh A, Hackett ML, Hankey GJ. Mead GE, et al. Int J Stroke. 2020 Jun;15(4):365-376. doi: 10.1177/1747493019879655. Epub 2019 Oct 17. Int J Stroke. 2020. PMID: 31619137
Fluoxetine was associated with better neurological scores and less depression. Among the four (n = 3283) high-quality RCTs, the only difference between groups was lower depression scores with fluoxetine. CONCLUSION: This class I evidence demonstrates that fluoxet
Fluoxetine was associated with better neurological scores and less depression. Among the four (n = 3283) high-quality RCTs, the only
Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial.
Dennis M, Forbes J, Graham C, Hackett ML, Hankey GJ, House A, Lewis S, Lundström E, Sandercock P, Mead G. Dennis M, et al. Stroke. 2019 Nov;50(11):3280-3282. doi: 10.1161/STROKEAHA.119.026639. Epub 2019 Aug 20. Stroke. 2019. PMID: 31426731 Clinical Trial.
Background and Purpose- The FOCUS trial (Fluoxetine or Control Under Supervision) showed that fluoxetine did not improve modified Rankin Scale scores (mRS) but increased the risk of fractures. ...Although many fractures were serious, and likely to impair patients' f …
Background and Purpose- The FOCUS trial (Fluoxetine or Control Under Supervision) showed that fluoxetine did not improve modif …
Fluoxetine for stroke recovery improvement - the doubleblind, randomised placebo-controlled FOCUS-Poland trial.
Bembenek JP, Niewada M, Kłysz B, Mazur A, Kurczych K, Głuszkiewicz M, Członkowska A. Bembenek JP, et al. Neurol Neurochir Pol. 2020;54(6):544-551. doi: 10.5603/PJNNS.a2020.0099. Epub 2020 Dec 29. Neurol Neurochir Pol. 2020. PMID: 33373036 Free article. Clinical Trial.
AIM OF STUDY: The Fluoxetine Or Control Under Supervision (FOCUS)-Poland trial tested in a Polish cohort the hypothesis that fluoxetine improves recovery after stroke. ...However, patients receiving fluoxetine required therapy with additional antidepressant m …
AIM OF STUDY: The Fluoxetine Or Control Under Supervision (FOCUS)-Poland trial tested in a Polish cohort the hypothesis that fluox
Olanzapine plus fluoxetine for bipolar disorder: a systematic review and meta-analysis.
Silva MT, Zimmermann IR, Galvao TF, Pereira MG. Silva MT, et al. J Affect Disord. 2013 Apr 25;146(3):310-8. doi: 10.1016/j.jad.2012.11.001. Epub 2012 Dec 4. J Affect Disord. 2013. PMID: 23218251 Review.
BACKGROUND: Olanzapine plus fluoxetine combination (OFC) is one of the current approaches for treating the depressive phase of bipolar disorder. ...
BACKGROUND: Olanzapine plus fluoxetine combination (OFC) is one of the current approaches for treating the depressive phase of bipola …
1,666 results